Complex Partial Seizures

• FDA label_change · 2024-12-17
  FDA Approved: VIGABATRIN — Supplemental Application (Actavis Pharma, Inc.)

  FDA granted a supplemental approval for Vigabatrin by Actavis Pharma, Inc., updating the product under the ANDA process.

• FDA label_change · 2024-09-12
  FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)

  The FDA approved a supplemental application for Sabril (vigabatrin) by Lundbeck Pharmaceuticals LLC, resulting in a label change to reflect …

• FDA label_change · 2020-10-02
  FDA Approved: VIGABATRIN — Supplemental Application (Par Health USA, LLC)

  The FDA approved a supplemental application for Vigabatrin from Par Health USA, LLC, resulting in updated labeling for the product.

• FDA label_change · 2019-05-31
  FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)

  The FDA approved a supplemental application for SABRIL (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC, resulting in a labeling chang…

• FDA label_change · 2014-04-03
  FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)

  FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2013-10-26
  FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)

  The FDA approved a supplemental application for SABRIL (vigabatrin) from Lundbeck Pharmaceuticals LLC, addressing changes to the product lab…